NewGenIvf Group Stock Scheduled to Reverse Split on Monday, July 6th (NASDAQ:NIVF)

NewGenIvf Group Limited (NASDAQ:NIVF) shares are set to reverse split on the morning of Monday, July 6th. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, July 5th.

NewGenIvf Group Stock Down 16.4%

Shares of NASDAQ:NIVF traded down $0.09 during midday trading on Thursday, hitting $0.46. The company’s stock had a trading volume of 876,271 shares, compared to its average volume of 3,003,845. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. The stock’s 50 day simple moving average is $0.97 and its 200 day simple moving average is $3.34. NewGenIvf Group has a fifty-two week low of $0.43 and a fifty-two week high of $295.17.

NewGenIvf Group (NASDAQ:NIVF) last posted its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The firm had revenue of $1.42 million during the quarter. As a group, equities analysts forecast that NewGenIvf Group will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Insider Buying and Selling at NewGenIvf Group

In related news, major shareholder Financial Lp Hrt sold 85,317 shares of NewGenIvf Group stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $0.80, for a total transaction of $68,253.60. Following the sale, the insider directly owned 54,561 shares of the company’s stock, valued at $43,648.80. This trade represents a 60.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 31.80% of the company’s stock.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.